Telomerase reverse transcriptase locus polymorphisms and cancer risk: A field synopsis and meta-analysis

Journal of the National Cancer Institute

Volumn 104, Issue 11, 2012, Pages 840-854

  Mocellin, Simone ^a   Verdi, Daunia ^a   Pooley, Karen A ^b   Landi, Maria T ^c   Egan, Kathleen M ^d   Baird, Duncan M ^e   Prescott, Jennifer ^f,g   De Vivo, Immaculata ^f,g   Nitti, Donato ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c NATIONAL CANCER INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

BLADDER CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; EMBASE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HUMAN; LUNG CANCER; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TELOMERASE;

EID: 84862183505     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs222     Document Type: Review

References (94)

1. Blackburn EH. Switching and signaling at the telomere. Cell. 2001 ; 106 (6): 661-673
2. de Lange T. How telomeres solve the end-protection problem. Science. 2009; 326 (5955): 948-952
3. Bianchi A, Shore D. How telomerase reaches its end: mechanism of telomerase regulation by the telomeric complex. Mol Cell. 2008 ; 31 (2): 153-165
4. Osterhage JL, Friedman KL.Chromosome end maintenance by telomerase J Biol Chem. 2009; 284 (24): 16061-16065
5. Blasco MA. Telomeres and human disease: ageing, cancer and beyond Nat Rev Genet. 2005; 6 (8): 611-622
6. Calado RT, Young NS. Telomere diseases. N Engl J Med. 2009; 361 (24): 2353-2365
7. Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer. 2008; 8 (3): 167-179
8. Liu JP, Chen W, Schwarer AP, Li H. Telomerase in cancer immunotherapy . Biochim Biophys Acta. 2010; 1805 (1): 35-42
9. Baird DM. Variation at the TERT locus and predisposition for cancer Expert Rev Mol Med. 2010; 12: e16
10. Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008; 37 (1): 120-132
11. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6 (7): e1000097
12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283 (15): 2008-2012
13. Mocellin S, Rossi CR. The Melanoma Molecular Map Project. Melanoma Res. 2008; 18 (3): 163-165
14. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis Stat Med. 2002; 21: 1539-1558
15. Sterne JA, Gavaghan D, Egger M. Publication and related bias in metaanalysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000; 53 (11): 1119-1129
16. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56 (2): 455-463
17. Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007; 4 (3): 245-253
18. Stacey SN, Sulem P, Masson G, et al. New common variants affecting susceptibility to basal cell carcinoma. Nat Genet. 2009; 41 (8): 909-914
19. Watcholder S. The impact of a prevention effort on the community Epidemiology. 2005; 16 (1): 1-3
20. Sagoo GS, Little J, Higgins JP. Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med. 2009 ; 6 (3): e28
21. Wang L, Soria JC, Chang YS, Lee HY, Wei Q, Mao L. Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene. 2003; 22 (46): 7123-7129
22. Carpentier C, Lejeune J, Gros F, et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol. 2007; 84 (3): 249-253
23. Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet. 2007; 39 (7): 870-874
24. Savage SA, Chanock SJ, Lissowska J, et al. Genetic variation in five genes important in telomere biology and risk for breast cancer. Br J Cancer. 2007; 97 (6): 832-836
25. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet. 2007 ; 39 (5): 645-649
26. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008; 40 (5): 616-622
27. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008; 40 (3): 316-321
28. Hosgood HD III, Menashe I, Shen M, et al. Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway. Carcinogenesis. 2008; 29 (10): 1938-1943
29. McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet. 2008; 40 (12): 1404-1406
30. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008; 452 (7187): 638-642
31. Tomlinson IP, Webb E, Carvajal-Carmona L, et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet. 2008; 40 (5): 623-630
32. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants infl uence lung cancer risk. Nat Genet. 2008; 40 (12): 1407-1409
33. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009; 41 (9): 986-990
34. Andersson U, Osterman P, Sjostrom S, et al. MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome. Int J Cancer. 2009; 125 (4): 968-972
35. Andrew AS, Gui J, Sanderson AC, et al. Bladder cancer SNP panel predicts susceptibility and survival. Hum Genet. 2009; 125 (5-6): 527-539
36. Calado RT, Regal JA, Hills M, et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA. 2009; 106 (4): 1187-1192
37. Choi JE, Kang HG, Jang JS, et al. Polymorphisms in telomere maintenance genes and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. 2009; 18 (10): 2773-2781
38. Falchi M, Bataille V, Hayward NK, et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet. 2009; 41 (8): 915-919 14 Review | JNCI
39. Jin G, Xu L, Shu Y, et al. Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population. Carcinogenesis 2009; 30 (6): 987-990
40. Landi MT, Chatterjee N, Yu K, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet. 2009; 85 (5): 679-691
41. Rafnar T, Sulem P, Stacey SN, et al. Sequence variants at the TERTCLPTM1L locus associate with many cancer types. Nat Genet. 2009; 41 (2) : 221-227
42. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009 ; 41 (8): 899-904
43. Song W, Ruder AM, Hu L, et al. Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs. PLoS One. 2009; 4 (9): e7157
44. Van Dyke AL, Cote ML, Wenzlaff AS, et al. Chromosome 5p region SNPs are associated with risk of NSCLC among women. J Cancer Epidemiol. 2009; 2009: 242151
45. Varadi V, Brendle A, Grzybowska E, et al. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer. Cancer Genet Cytogenet. 2009; 190 (2): 71-74
46. Wrensch M, Jenkins RB, Chang JS, et al. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet. 2009; 41 (8): 905-908
47. Zienolddiny S, Skaug V, Landvik NE, et al. The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis. 2009; 30 (8): 1368-1371
48. Bei JX, Li Y, Jia WH, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet. 2010 ; 42 (7): 599-603
49. Clifford RJ, Zhang J, Meerzaman DM, et al. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology. 2010; 52 (6): 2034-2043
50. Gudmundsson J, Besenbacher S, Sulem P, et al. Genetic correction of PSA values using sequence variants associated with PSA levels. Sci Transl Med. 2010; 2 (62): 62-92
51. Guey LT, Garcia-Closas M, Murta-Nascimento C. Genetic susceptibility to distinct bladder cancer subphenotypes. Eur Urol. 2010; 57: 283-292
52. Hsiung CA, Lan Q, Hong YC, et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 2010; 6 (8): e1001051
53. Johnatty SE, Beesley J, Chen X, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet. 2010; 6 (7): e1001016
54. Kohno T, Kunitoh H, Shimada Y, et al. Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes Carcinogenesis. 2010; 31 (5): 834-841
55. Lascorz J, Forsti A, Chen B, et al. Genome-wide association study for colorectal cancer identifies risk polymorphisms in German familial cases and implicates MAPK signalling pathways in disease susceptibility Carcinogenesis. 2010; 31 (9): 1612-1619
56. Liu Z, Li G, Wei S, et al. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2010; 31 (11): 1977-1981
57. Miki D, Kubo M, Takahashi A, et al. Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations Nat Genet. 2010; 42 (10): 893-896
58. Petersen GM, Amundadottir L, Fuchs CS, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet. 2010; 42 (3): 224-228
59. Pooley KA, Tyrer J, Shah M, et al. No association between TERTCLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk. Cancer Epidemiol Biomarkers Prev. 2010; 19 (7): 1862-1865
60. Prescott J, McGrath M, Lee IM, Buring JE, De Vivo I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer. 2010; 116 (18): 4275-4282
61. Rothman N, Garcia-Closas M, Chatterjee N, et al. A multi-stage genomewide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010; 42 (11): 978-984
62. Shen J, Gammon MD, Wu HC, et al. Multiple genetic variants in telomere pathway genes and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2010; 19 (1): 219-228
63. Truong T, Hung RJ, Amos CI, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst. 2010 ; 102 (13): 959-971
64. Turnbull C, Rapley EA, Seal S, et al. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet. 2010; 42 (7): 604-607
65. Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS. Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis. 2010; 31 (2): 234-238
66. Yang P, Li Y, Jiang R, Cunningham JM, Zhang F, de Andrade M. A rigorous and comprehensive validation: common genetic variations and lung cancer. Cancer Epidemiol Biomarkers Prev. 2010; 19 (1): 240-244
67. Yoon KA, Park JH, Han J, et al. A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population . Hum Mol Genet. 2010; 19 (24): 4948-4954
68. Yoon SL, Jung SI, Do EJ, et al. Short rare hTERT-VNTR2-2nd alleles are associated with prostate cancer susceptibility and infl uence gene expression. BMC Cancer. 2010; 10: 393
69. Chen H, Chen Y, Zhao Y, et al. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol. 2011; 173 (8): 915-922
70. Egan KM, Thompson RC, Nabors LB, et al. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011; 104 (2): 535-542
71. Gago-Dominguez M, Jiang X, Conti DV, et al. Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis. 2011 ; 32 (2): 197-202
72. Hofer P, Baierl A, Feik E, et al. MNS16A tandem repeats minisatellite of human telomerase gene: a risk factor for colorectal cancer. Carcinogenesis. 2011; 32 (6): 866-871
73. Hu Z, Wu C, Shi Y, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet. 2011; 43 (8): 792-796
74. Jin G, Yoo SS, Cho S, et al. Dual roles of a variable number of tandem repeat polymorphism in the TERT gene in lung cancer. Cancer Sci. 2011; 102 (1): 144-149
75. Nan H, Qureshi AA, Prescott J, De Vivo I, Han J. Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet. 2011 ; 129 (3): 247-253
76. Kanetsky PA, Mitra N, Vardhanabhuti S, et al. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility . Hum Mol Genet. 2011; 20 (15): 3109-3117
77. Kohno T, Kunitoh H, Mimaki S, et al. Contribution of the TP53, OGG1, CHRNA3, and HLA-DQA1 genes to the risk for lung squamous cell carcinoma. J Thorac Oncol. 2011; 6 (4): 813-817
78. Kote-Jarai Z, Olama AA, Giles GG, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet. 2011; 43 (8): 785-791
79. Kratz CP, Han SS, Rosenberg PS, et al. Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet. 2011; 48 (7): 473-476
80. Pande M, Spitz MR, Wu X, Gorlov IP, Chen W, Amos CI. Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis. 2011; 32 (10): 1493-1499
81. Peters U, Hutter CM, Hsu L, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet. 2012; 131 (2): 217-234
82. Wang K, Diskin SJ, Zhang H, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011; 469 (7329): 216-220 jnci.oxfordjournals.org
83. Wauters E, Smeets D, Coolen J, et al. The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. Eur Respir J. 2011; 38 (4): 924-931
84. Young RP, Hopkins RJ, Whittington CF, Hay BA, Epton MJ, Gamble GD Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD. PLoS One. 2011; 6 (2): e16476
85. Taylor J, Tyekucheva S, King DC, Hardison RC, Miller W, Chiaromonte F ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res. 2006; 16 (12): 1596-1604
86. Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet. 2009; 84 (1): 52-59
87. Mirabello L, Yu K, Kraft P, et al. The association of telomere length and genetic variation in telomere biology genes. Hum Mutat. 2010; 31: 1050-1058
88. Perona R, Machado-Pinilla R, Manguan C, Carrillo J. Telomerase deficiency and cancer susceptibility syndromes. Clin Transl Oncol. 2009 ; 11 (11): 711-714
89. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun. 2001; 280 (4): 1148-1154
90. Webb E, Broderick P, Lubbe S, Chandler I, Tomlinson I, Houlston RS A genome-wide scan of 10 000 gene-centric variants and colorectal cancer risk. Eur J Hum Genet. 2009; 17 (11): 1507-1514
91. Han J, Qureshi AA, Prescott J, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol. 2009; 129 (2): 415-421
92. Bataille V, Kato BS, Falchi M, et al. Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev. 2007; 16 (7): 1499-1502
93. Mocellin S, Nitti D. Cutaneous melanoma in situ: translational evidence from a large population-based study. Oncologist. 2011; 16 (6): 896-903
94. Riethman H. Human telomere structure and biology. Annu Rev Genomics Hum Genet. 2008; 9: 1-19